ProQR Therapeutics
-$0.17 (-3.23%) Today
+$0.25 (+4.90%) As of 1:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PRQR and other ETFs, options, and stocks.
About PRQR
ProQR Therapeutics NV is a biopharmaceutical company, which engages in the discovery and development of RNA therapies for the treatment of severe genetic rare diseases such as Leber congenital amaurosis 10, Usher syndrome and retinitis pigmentosa. Its product pipeline include Sepofarsen, QR-421a, QR-1123, and QR-504a.
CEO
Daniel Anton de Boer
Employees
150
Headquarters
Leiden, Zuid-Holland
Founded
2012
PRQR Key Statistics
Market cap
326.66M
Price-Earnings ratio
—
Dividend yield
—
Average volume
559.43K
High today
$5.33
Low today
$4.97
Open price
$5.23
Volume
508.71K
52 Week high
$9.46
52 Week low
$4.13
Analyst ratings
100%
of 8 ratings
Buy
100%
Hold
0%
Sell
0%
PRQR Earnings
-$0.31
-$0.21
-$0.10
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Feb 24, Pre-Market